Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes
Authors:
Open Access
- 27 June 2011
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 23 (2) , 298-304
Abstract
This paper explores the enigma of cancer of unknown primary (CUP) in relation to rapidly improving molecular diagnostic approaches. It is based on the first global collaboration meeting on improving research and clinical outcomes in CUP organized by the CUP Foundation. We review the difficulties of classifying this widely heterogeneous disease and the available diagnostic and pathological evaluative techniques, focusing on molecular profiling. Retrospective studies in CUP patients are shown to provide indirect validation of the accuracy of several platforms of gene expression profiling assays that may identify CUP subsets that respond favorably to active chemotherapy regimens. This review concludes that the recent major improvements in pathologic and molecular diagnostics, coupled with new improved therapies for several specific advanced solid tumors, need to be harmonized with more evidence from clinical–translational trials. All patients with CUP could thus be appropriately managed without the constant uncertainty that has previously severely hampered patient care and optimal outcomes. The longer-term objective is to understand the biology of highly metastatic disease, leading to the development of future global therapeutic programs. Current clinical studies, such as CUP-ONE, will address some of these issues.Keywords
This publication has 21 references indexed in Scilit:
- Molecular Classification of Cancers of Unknown Primary SiteMolecular Diagnosis & Therapy, 2009
- Pathologic Evaluation of Unknown Primary CancerSeminars in Oncology, 2009
- Treatment for Patients With Unknown Primary Cancer and Favorable Prognostic FactorsSeminars in Oncology, 2009
- Molecular Classification of Unknown Primary CancerSeminars in Oncology, 2009
- Clinical Utility of Microarrays: Current Status, Existing Challenges and Future OutlookCurrent Genomics, 2008
- Therapy of Adenocarcinoma of Unknown Primary: Are We Making Progress?Journal of the National Comprehensive Cancer Network, 2008
- Gene Expression Profiling to Identify the Histogenetic Origin of Metastatic Adenocarcinomas of Unknown PrimaryJournal of Clinical Oncology, 2008
- Carcinoma of unknown primary with a colon-cancer profile—changing paradigm and emerging definitionsThe Lancet Oncology, 2008
- Switching benchmarks in cancer of unknown primary: From autopsy to microarrayEuropean Journal of Cancer, 2007
- Markers of Adenocarcinoma Characteristic of the Site of Origin: Development of a Diagnostic AlgorithmClinical Cancer Research, 2005